Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive‐stage disease small cell lung cancer: Results from a randomized controlled trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive‐stage disease small cell lung cancer: Results from a randomized controlled trial
Authors
Keywords
-
Journal
Thoracic Cancer
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-11-11
DOI
10.1111/1759-7714.13229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Malnutrition and overall survival in older adults with cancer: A systematic review and meta-analysis
- (2019) Xiaotao Zhang et al. Journal of Geriatric Oncology
- Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning
- (2018) Jun Han et al. Lipids in Health and Disease
- Randomized Phase III Trial of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer
- (2018) Dong-Wan Kim et al. Cancer Research and Treatment
- Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy
- (2018) Shi Jin et al. Clinical Respiratory Journal
- The Prognostic Significance of the Geriatric Nutritional Risk Index in Patients with Esophageal Squamous Cell Carcinoma
- (2018) Kazuhiro Migita et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer
- (2018) Se-Il Go et al. Thoracic Cancer
- Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan
- (2018) Teppei Okamoto et al. WORLD JOURNAL OF UROLOGY
- The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer
- (2018) Naoshi Kubo et al. Esophagus
- Risk Factors for Surgical Site Infection after Soft-Tissue Sarcoma Resection, Including the Preoperative Geriatric Nutritional Risk Index
- (2018) Hiromi Sasaki et al. Nutrients
- Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer
- (2017) E.Y. Kim et al. EUROPEAN JOURNAL OF CANCER CARE
- Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
- (2017) Marcello Tiseo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study
- (2017) Fumihiro Shoji et al. Interactive Cardiovascular and Thoracic Surgery
- Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
- (2016) Neil M. Iyengar et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3 in the systemic inflammation of cancer cachexia
- (2016) Teresa A. Zimmers et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer
- (2016) Eun Young Kim et al. PLoS One
- Is the Geriatric Nutritional Risk Index a Significant Predictor of Postoperative Complications in Patients with Esophageal Cancer Undergoing Esophagectomy
- (2015) Ippei Yamana et al. EUROPEAN SURGICAL RESEARCH
- Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer
- (2015) Se-Il Go et al. SUPPORTIVE CARE IN CANCER
- Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer
- (2015) Ting Zhou et al. Scientific Reports
- Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma
- (2015) Weijie Gu et al. Journal of Cachexia Sarcopenia and Muscle
- The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
- (2014) M H Kang et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer
- (2014) Se-Il Go et al. MEDICAL ONCOLOGY
- Inflammation lights the way to metastasis
- (2014) Seth B. Coffelt et al. NATURE
- A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer
- (2014) Ting Zhou et al. TUMOR BIOLOGY
- The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients
- (2014) Shaodong Hong et al. TUMOR BIOLOGY
- Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
- (2012) Antonio Rossi et al. JOURNAL OF CLINICAL ONCOLOGY
- An Updated Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer
- (2012) Ning Shao et al. Journal of Thoracic Oncology
- Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer: Final Results of a Randomized Phase III Trial
- (2012) Thomas H. Fink et al. Journal of Thoracic Oncology
- Small-cell lung cancer
- (2011) Jan P van Meerbeeck et al. LANCET
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
- (2010) P. Zatloukal et al. ANNALS OF ONCOLOGY
- Prognostic factors differ by tumor stage for small cell lung cancer
- (2009) Nathan R. Foster et al. CANCER
- Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
- (2009) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
- (2008) Andreas Hermes et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now